Menu
Not yet recruiting NCT07241962

Hepatitis B and C Within the Chinese Community in Milan

Observational HBV (Hepatitis B Virus) HCV Infection

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: HBV (Hepatitis B Virus), HCV Infection. Basic parameters: 18 years — 50 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Prevalence of Hepatitis B and C Within the Chinese Community Residing in Milan

Overview

The goal of this observational study is to assess the effectiveness of targeted screening for Hepatitis B (HBV) and Hepatitis C (HCV) infections in adults aged 18 to 50 from the Chinese community residing in Milan. The main questions it aims to answer are: * Does community-based, culturally sensitive screening increase the detection of undiagnosed HBV and HCV infections in this high-risk population? * What is the level of adherence, satisfaction and awareness regarding rapid testing methods in this community? Participants will: * Receive pre-test counseling in Italian or Chinese with the help of an interpreter * Complete a brief, anonymous questionnaire on demographics, risk factors and awareness of HBV/HCV * Undergo capillary rapid testing for HBV and/or HCV * Receive test results during the same visit * Complete a short post-test satisfaction questionnaire The study will be conducted in public spaces within Milan's Chinatown, during monthly sessions, until 1,000 participants are enrolled. Each session will last approximately 30-60 minutes per participant.

Primary outcome measures

  • Detection rate of HBV and/or HCV infections [Time frame: Day 1 (during the screening session)]
Secondary outcome measures (4)
  • Adherence to rapid HBV/HCV testing [Time frame: Day 1]
  • Acceptability of rapid testing methods [Time frame: Day 1]
  • Demographic profile and risk factors of screened individuals [Time frame: Day 1]
  • Awareness of HBV and HCV infections [Time frame: Day 1]

Eligibility criteria

Inclusion criteria

  • Adults aged 18 to 50 years
  • Self-identified as part of the Chinese community residing in Milan
  • Willing and able to provide informed consent
  • Willing to undergo HBV and/or HCV rapid screening (capillary blood test)
  • Able to complete an anonymous questionnaire on demographics, risk factors and awareness of HBV and HCV infections
  • Able to communicate in Italian or Chinese (with interpreter assistance, if needed)

Exclusion criteria

  • Age under 18 or over 50 years
  • Not from the Chinese community or not residing in Milan
  • Unable to provide informed consent
  • Currently undergoing treatment for HBV or HCV, or with previously confirmed diagnosis of HBV or HCV
  • Severe mental or physical illness impairing participation or understanding of consent
  • Unable to respond to the questionnaire, even with interpreter assistance
  • Pregnant women

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07241962 · OBS-CHN-2025

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗